Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
Clinicians have very limited options to treat triple-negative breast cancer (TNBC) due to the lack of effective targeted drugs. Recently, the findings of the mechanism underlying tumor-intrinsic immune escape have fueled a wave of studies into immunotherapy in breast cancer (BC). Compared with other...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b70b5e3637074d7693e3d1e8c38ef8fc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!